Patent-end-to-end (PE2E) biosequence
Ended Awarded Last action
- Contract number
- 1333BJ20F00280051
- Awardee
-
Salient Crgt, Inc. UEI Q5LJNF15T2R5
- Awarding agency
-
US Patent and Trademark Office
Department of Commerce
- Obligated
- -$202,650
Award facts
- Opportunity
-
- 1333BJ20Q00280067 Solicitation number
- Contract value 0% obligated
- $5,211,087.87 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541512 Computer Systems Design Services
- PSC
- D302 It And Telecom- Systems Development
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Labor Hours
- Place of performance
- Fairfax, VA 22033, USA
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$64,037 | |
| Funding Only Action | -$463,162 | |
| Supplemental Agreement for work within scope | $380,772 | |
| Exercise an Option | $692,174 | |
| Supplemental Agreement for work within scope | $1,384,348 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $2,673,617 | |
| Exercise an Option | $241,063 | |
| Exercise an Option | $41,764 | |
| Original award | $324,549 |
Show all 11
About this award
The U.S. Patent and Trademark Office awarded a delivery order valued at $5.2 million to Salient CRGT, Inc. for Patent-End-to-End (PE2E) Biosequence Replacement Systems Engineering and Life Cycle Support Services under an Agile delivery model. The contract, which closed on April 28, 2022, was issued without a set-aside designation and performed in Fairfax, Virginia. This delivery order operates as a child contract under the Software Development and Integration Next Generation (SDI-NG) parent IDIQ, a government-wide acquisition contract vehicle that enables flexible procurement of IT and professional services across federal agencies.
Salient CRGT, Inc., a Virginia-based professional services and information technology solutions provider, has extensive experience supporting federal civilian and defense agencies through digital transformation, software development, systems integration, and program management services. The company maintains a diverse federal contract portfolio exceeding $3 billion in total value across multiple IDVs and parent contract vehicles, including the Alliant II, OASIS, and SWIFT platforms. The PE2E biosequence systems engineering effort reflects the firm's demonstrated capability to deliver complex technical support and lifecycle management services, leveraging its established relationships with civilian agencies and track record of agile software development and integration projects.
Quick answers
Who was awarded contract 1333BJ20F00280051?
1333BJ20F00280051 was awarded to Salient Crgt, Inc. by US Patent and Trademark Office (Department of Commerce) on June 8, 2020.
How much is contract 1333BJ20F00280051 worth?
The government has obligated -$202,650 on 1333BJ20F00280051. Its current value, with exercised options, is $5,211,088.
Is contract 1333BJ20F00280051 an order under another contract?
Yes. 1333BJ20F00280051 is a delivery order under DOC50PAPT1600027, an indefinite delivery contract, on Software Development and Integration Next Generation (SDI-NG).
Was contract 1333BJ20F00280051 competed?
The extent of competition for 1333BJ20F00280051 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award